Switch to Dark

Pricing

Learn

PFE - Pfizer Inc

539

$27.45

$0.84 (3.157%)

At market close

$27.48

$0.03 (0.091%)

Pre Market 3/18/26, 10:46 AM

Score

3.25/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Pfizer Inc

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	38.64%	28.02%	$15.65B	$15.65B	$13.72B 2025-03-30	$17.56B 2025-12-31	$17.56B 2025-12-31

Operating Expenses	37.84%	27.46%	$6.86B	$6.72B	$6.16B 2025-03-30	$7.85B 2025-12-31	$7.85B 2025-12-31

Net Interest Income Expense	--	41.32%	-$533.50M	-$470.00M	-$881.00M 2025-03-30	-$313.00M 2025-09-28	-$517.00M 2025-12-31

Income Tax Expense	--	98.94%	-$66.50M	-$95.50M	-$216.00M 2025-09-28	$141.00M 2025-06-29	-$2.00M 2025-12-31

Cost of Goods Sold (COGS)	143%	95.41%	$3.78B	$3.74B	$2.59B 2025-03-30	$5.07B 2025-12-31	$5.07B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-28	2025-06-29	2025-03-30	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-29	2024-06-30	2024-03-31	2023-12-31	2023-10-01	2023-07-02	2023-04-02	2022-12-31	2022-10-02	2022-07-03	2022-04-03	2021-12-31	2021-10-03
Total Revenue	17,558,000	16,654,000	14,653,000	13,715,000	42,069,000	5988665	2552042	6805727	5800665	4499906	5006963	4748028	9384541	465449	9600098	6698058	5109476	934208
Cost of Goods Sold (COGS)	5,065,000	3,979,000	3,502,000	2,592,000	42,069,000	5309381	2589522	3147932	1647883	7968603	5172288	1488156	3116899	1215491	8277905	5175797	6941914	7680240
Gross Profit	12,493,000	12,675,000	11,151,000	11,123,000	42,069,000	1838865	2759051	4869527	7088596	5813975	3645066	4626029	7382869	5164768	1262290	122590	1332683	9881181
Operating Expenses	7,848,000	6,603,000	6,827,000	6,157,000	42,069,000	4992502	5446598	6530619	6633921	2868455	7615173	1272346	8814653	6674257	7891093	4608084	1567900	6944851
Research & Development	3,206,000	2,493,000	2,443,000	2,179,000	42,069,000	2379587	6861343	7871221	2359233	4837589	5387269	4104402	8165323	8252200	6414145	3944565	5130528	26556
Selling, General & Administrative Expenses	4,080,000	3,158,000	3,395,000	3,009,000	42,069,000	1183020	8071983	5801438	4450262	8846053	607921	1497468	326080	4831697	8470946	6148321	662624	910941
Operating Income or Loss	4,645,000	6,072,000	4,324,000	4,966,000	42,069,000	6935749	368190	9214409	9549671	6397137	2808774	9914873	381351	6380333	8209061	5973788	6305048	9471305
Interest Expense	-711,000	-652,000	-654,000	-654,000	42,069,000	7656649	7697213	8643212	2852870	3303679	676110	954321	7757199	9497026	2723143	1377505	8474510	2316082
Net Interest Income Expense	-517,000	-313,000	-423,000	-881,000	42,069,000	7445086	4420046	3715201	5617859	1656570	8707522	2524958	969860	798358	7557240	9261718	2035840	5107763
Non-Recurring Items	-5,770,000	-2,425,000	-857,000	-1,300,000	42,069,000	5501736	1543800	3901863	6345155	9106857	1002758	4840285	4632748	7101315	4532513	1608185	2254111	4590706
Total Other Income/Expense Net	--	--	--	--	--	2340223	267410	1476841	6011449	--	--	720478	32706	8849517	--	5223799	2870484	--
Income Before Tax	-1,642,000	3,334,000	3,044,000	2,785,000	42,069,000	7903952	1319766	4852715	4723539	3954190	2629291	5553064	7230544	2495448	1416844	6459389	7207910	607769
Income Tax Expense	-2,000	-216,000	141,000	-189,000	42,069,000	785917	3558256	9434326	9582875	2308355	9012707	1412731	6049188	396438	4973484	2585280	4561356	9065840
Earnings	-1,648,000	3,541,000	2,910,000	2,967,000	42,069,000	5953336	7035157	718954	2686188	1418570	5045436	8426932	8445454	5895315	6349925	413450	7200767	6895037
Adjusted Net Income	-7,418,000	1,116,000	2,053,000	1,667,000	42,069,000	9437543	6180385	7363911	6076370	1227286	7627776	1739338	5086738	6072793	8919367	3460168	1163914	9938841
Net Income After Taxes	-1,640,000	3,550,000	2,903,000	2,974,000	42,069,000	2291487	6852362	3225703	3331284	3763704	1076675	7867585	3985487	1844869	5190893	1195768	3062159	1976038
Diluted Shares Outstanding	5,686,000	5,714,000	5,706,000	5,710,000	42,069	8914491	9389845	3771253	8822516	3511596	8119312	2153072	2803469	3800453	69958	2114350	3454713	6023812
Diluted EPS	-0.29	0.62	0.51	0.52	42,069	7322699	1540161	1967067	7424682	1968558	8915985	5502131	7033401	2351368	7142708	6496061	4015801	8074110
Adjusted EPS	-1.3	0.2	0.36	0.29	42,069	259223	6644102	2604543	5850029	9279962	3368686	2670943	2343101	7371572	7834507	2443350	3417042	7520991
EBITDA	6,332,000	7,734,000	5,949,000	6,584,000	42,069,000	7548494	180683	3404333	8949608	7296635	1019525	9367447	6947922	6753444	211089	2823242	3440598	1962021